Literature DB >> 17273554

A link between protein translation and body weight.

Liangyou Rui1.   

Abstract

Nutrient overload induces obesity, a primary risk factor for type 2 diabetes. Ribosomal biogenesis and protein synthesis, which are controlled by the mammalian target of rapamycin (mTOR), are primary energy-consuming processes in cells. mTOR phosphorylates and inactivates members of the eukaryotic translation initiation factor 4E-binding (eIF4E-binding) protein (4E-BP) family, which are translational repressors of 5' cap-dependent protein synthesis. In this issue of the JCI, Le Bacquer et al. report that simultaneous deletion of both 4E-BP1 and 4E-BP2 in mice results in insulin resistance, decreased energy expenditure, and increased adipogenesis (see the related article beginning on page 387). These findings link protein synthesis, insulin sensitivity, and body weight.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273554      PMCID: PMC1783829          DOI: 10.1172/JCI31289

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.

Authors:  Olivier Le Bacquer; Emmanuel Petroulakis; Sabina Paglialunga; Francis Poulin; Denis Richard; Katherine Cianflone; Nahum Sonenberg
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

2.  Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1.

Authors:  K Tsukiyama-Kohara; F Poulin; M Kohara; C T DeMaria; A Cheng; Z Wu; A C Gingras; A Katsume; M Elchebly; B M Spiegelman; M E Harper; M L Tremblay; N Sonenberg
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

3.  mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

Authors:  Marina K Holz; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Cell       Date:  2005-11-18       Impact factor: 41.582

4.  Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase.

Authors:  Marina K Holz; John Blenis
Journal:  J Biol Chem       Date:  2005-05-19       Impact factor: 5.157

5.  Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro.

Authors:  S Isotani; K Hara; C Tokunaga; H Inoue; J Avruch; K Yonezawa
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

6.  Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice.

Authors:  M Pende; S C Kozma; M Jaquet; V Oorschot; R Burcelin; Y Le Marchand-Brustel; J Klumperman; B Thorens; G Thomas
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

7.  Hypothalamic mTOR signaling regulates food intake.

Authors:  Daniela Cota; Karine Proulx; Kathi A Blake Smith; Sara C Kozma; George Thomas; Stephen C Woods; Randy J Seeley
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

8.  Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.

Authors:  Leila Khamzina; Alain Veilleux; Sébastien Bergeron; André Marette
Journal:  Endocrinology       Date:  2004-12-16       Impact factor: 4.736

9.  4E-BP functions as a metabolic brake used under stress conditions but not during normal growth.

Authors:  Aurelio A Teleman; Ya-Wen Chen; Stephen M Cohen
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

10.  Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.

Authors:  H Shima; M Pende; Y Chen; S Fumagalli; G Thomas; S C Kozma
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more
  6 in total

1.  Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.

Authors:  F Cortazar; M Z Molnar; T Isakova; M E Czira; C P Kovesdy; D Roth; I Mucsi; M Wolf
Journal:  Am J Transplant       Date:  2011-11-04       Impact factor: 8.086

Review 2.  Metabolic syndrome as a risk factor for neurological disorders.

Authors:  Akhlaq A Farooqui; Tahira Farooqui; Francesco Panza; Vincenza Frisardi
Journal:  Cell Mol Life Sci       Date:  2011-10-15       Impact factor: 9.261

Review 3.  Recent advances in understanding leptin signaling and leptin resistance.

Authors:  David L Morris; Liangyou Rui
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-09-01       Impact factor: 4.310

4.  Novel polysome messages and changes in translational activity appear after induction of adipogenesis in 3T3-L1 cells.

Authors:  Carolin Fromm-Dornieden; Silvia von der Heyde; Oleksandr Lytovchenko; Gabriela Salinas-Riester; Bertram Brenig; Tim Beissbarth; Bernhard G Baumgartner
Journal:  BMC Mol Biol       Date:  2012-03-21       Impact factor: 2.946

Review 5.  The role of amino acid-induced mammalian target of rapamycin complex 1(mTORC1) signaling in insulin resistance.

Authors:  Mee-Sup Yoon; Cheol Soo Choi
Journal:  Exp Mol Med       Date:  2016-01-08       Impact factor: 8.718

Review 6.  Role of adipokines signaling in the modulation of T cells function.

Authors:  Claudio Procaccini; Veronica De Rosa; Mario Galgani; Fortunata Carbone; Claudia La Rocca; Luigi Formisano; Giuseppe Matarese
Journal:  Front Immunol       Date:  2013-10-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.